Company: GRCE
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001140361-25-041804
Chunk: 57

Company: Grace Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Item 8
Chunk 57
---
centivePlanMember

    2025-09-30

    0001444192
    
      grce:EquityIncentivePlan2024Member

    2025-09-30

    0001444192
    
      grce:StockOptionPlanMember

    2025-04-01
    2025-09-30

    0001444192
    
      grce:EquityIncentivePlanMember

    2025-04-01
    2025-09-30

    0001444192
    
      grce:StockOptionPlanMember

    2025-09-30

    0001444192
    
      grce:StockOptionPlanMember

    2025-03-31

    0001444192
    
      us-gaap:EmployeeStockOptionMember

    2025-09-30

    0001444192
    
      us-gaap:EmployeeStockOptionMember

    2024-09-30

    0001444192
    
      us-gaap:EmployeeStockOptionMember

    2025-04-01
    2025-09-30

    0001444192
    
      us-gaap:EmployeeStockOptionMember

    2024-04-01
    2024-09-30

    0001444192
    
      us-gaap:ResearchAndDevelopmentExpenseMember
      grce:EquityIncentivePlan2024Member

    2025-07-01
    2025-09-30

    0001444192
    
      us-gaap:ResearchAndDevelopmentExpenseMember
      grce:EquityIncentivePlan2024Member

    2024-07-01
    2024-09-30

    0001444192
    
      us-gaap:ResearchAndDevelopmentExpenseMember
      grce:EquityIncentivePlan2024Member

    2025-04-01
    2025-09-30

    0001444192
    
      us-gaap:ResearchAndDevelopmentExpenseMember
      grce:EquityIncentivePlan2024Member

    2024-04-01
    2024-09-30

    0001444192
    
      us-gaap:GeneralAndAdministrative